The Union Ministry of Health (MoHFW) and BMC Mumbai are at loggerheads over whether a case of a new sub-variant XE of Corona has come to the fore. The health ministry has refuted the BMC’s claims, saying that genome sequencing of the patient’s sample did not confirm the XE variant. At the same time, top officials of INSACOG, a central research institute under the Ministry of Health, said that the matter would have to be re-examined.
Earlier on Wednesday, the Municipal Corporation of Greater Mumbai claimed that out of 230 samples sent for testing under genome sequencing, the test for the new sub-variant XE was confirmed. It was also alleged in this case that a 50-year-old woman who had no symptoms of corona was found infected with the new sub-variant XE of the corona. The woman has received both doses of the vaccine. According to the BMC, the sample will be sent to the National Institute of Biomedical Genomics (NIBMG) for confirmation of the new variant.
Regarding this new variant, the World Health Organization (WHO) has said that the ‘XE’ variant has been confirmed in Britain a few days ago. The WHO says the Xe sub-variant appears to be 10% more infectious than Omicron’s Ba.2. The WHO states that the XE mutation is currently being tracked as part of the Omicron variant. Symptoms of Omicron include fever, sore throat, cough, cold, skin irritation, etc. The UK Department of Health is studying XD, XE and XF. XD is taken from Omicron’s BA.1. If the newer version is XE, it can be about 10 percent more infectious and lethal than Omicron’s sub-version BA.2.